Acumen Pharmaceuticals Inc
NASDAQ:ABOS

Watchlist Manager
Acumen Pharmaceuticals Inc Logo
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Watchlist
Price: 1.94 USD 4.3%
Market Cap: 117.5m USD

Wall Street
Price Targets

ABOS Price Targets Summary
Acumen Pharmaceuticals Inc

Wall Street analysts forecast ABOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABOS is 6.63 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Lowest
Price Target
4.04 USD
108% Upside
Average
Price Target
6.63 USD
242% Upside
Highest
Price Target
10.5 USD
441% Upside
Acumen Pharmaceuticals Inc Competitors:
Price Targets
BMRN
Biomarin Pharmaceutical Inc
74% Upside
PRTA
Prothena Corporation PLC
98% Upside
NIOX
Niox Group PLC
17% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
32% Upside
NVAX
Novavax Inc
93% Upside
PTCT
PTC Therapeutics Inc
8% Upside
ARWR
Arrowhead Pharmaceuticals Inc
14% Downside
ZEAL
Zealand Pharma A/S
48% Upside

Revenue
Forecast

Revenue Estimate
Acumen Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Acumen Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Acumen Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABOS's stock price target?
Price Target
6.63 USD

According to Wall Street analysts, the average 1-year price target for ABOS is 6.63 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Back to Top